1. Home
  2. JOB vs ENLV Comparison

JOB vs ENLV Comparison

Compare JOB & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GEE Group Inc.

JOB

GEE Group Inc.

HOLD

Current Price

$0.20

Market Cap

20.4M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.83

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JOB
ENLV
Founded
1893
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
26.6M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
JOB
ENLV
Price
$0.20
$0.83
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
233.2K
11.7M
Earning Date
12-17-2025
11-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$96,504,000.00
N/A
Revenue This Year
$43.94
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.17
$0.79
52 Week High
$0.51
$2.10

Technical Indicators

Market Signals
Indicator
JOB
ENLV
Relative Strength Index (RSI) 57.04 36.48
Support Level $0.18 $0.80
Resistance Level $0.19 $0.88
Average True Range (ATR) 0.01 0.10
MACD 0.00 -0.02
Stochastic Oscillator 93.33 6.96

Price Performance

Historical Comparison
JOB
ENLV

About JOB GEE Group Inc.

GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: